SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $430,545 | -99.5% | 39,645 | -99.2% | 0.00% | -100.0% |
| Q1 2024 | $89,056,171 | -32.2% | 4,752,197 | -21.6% | 0.02% | -33.3% |
| Q4 2023 | $131,363,453 | -2.9% | 6,061,996 | -7.8% | 0.02% | -11.1% |
| Q3 2023 | $135,257,109 | -54.8% | 6,572,260 | +3.3% | 0.03% | -52.6% |
| Q2 2023 | $299,217,883 | +24.8% | 6,363,630 | +11.4% | 0.06% | +18.8% |
| Q1 2023 | $239,777,189 | +14.0% | 5,714,423 | +3.6% | 0.05% | +14.3% |
| Q4 2022 | $210,385,427 | +8.9% | 5,516,136 | +11.8% | 0.04% | +2.4% |
| Q3 2022 | $193,158,000 | +25.9% | 4,932,518 | +3.9% | 0.04% | +32.3% |
| Q2 2022 | $153,413,000 | -33.7% | 4,749,623 | -32.1% | 0.03% | -22.5% |
| Q1 2022 | $231,535,000 | -23.6% | 6,995,000 | -1.8% | 0.04% | -16.7% |
| Q4 2021 | $303,158,000 | +1.1% | 7,126,411 | +5.3% | 0.05% | -5.9% |
| Q3 2021 | $299,976,000 | -9.1% | 6,769,933 | +16.5% | 0.05% | -7.3% |
| Q2 2021 | $330,177,000 | -14.6% | 5,811,940 | +12.5% | 0.06% | -19.1% |
| Q1 2021 | $386,659,000 | +4.3% | 5,165,789 | +20.6% | 0.07% | 0.0% |
| Q4 2020 | $370,577,000 | +2442.0% | 4,283,629 | +1696.0% | 0.07% | +2166.7% |
| Q3 2020 | $14,578,000 | +142.9% | 238,508 | +65.2% | 0.00% | +200.0% |
| Q2 2020 | $6,001,000 | -91.5% | 144,347 | -85.2% | 0.00% | -93.3% |
| Q4 2019 | $70,429,000 | -74.8% | 975,613 | -51.0% | 0.02% | -76.2% |
| Q3 2019 | $279,069,000 | -30.4% | 1,989,227 | -9.2% | 0.06% | -29.2% |
| Q2 2019 | $400,907,000 | +14.2% | 2,189,672 | -0.8% | 0.09% | +11.2% |
| Q1 2019 | $351,080,000 | +90.7% | 2,207,361 | +14.9% | 0.08% | +73.9% |
| Q4 2018 | $184,093,000 | -33.9% | 1,921,835 | -2.5% | 0.05% | -22.0% |
| Q3 2018 | $278,372,000 | -10.2% | 1,970,770 | -0.5% | 0.06% | -14.5% |
| Q2 2018 | $310,163,000 | -15.1% | 1,981,504 | -12.7% | 0.07% | -16.9% |
| Q1 2018 | $365,390,000 | +7.0% | 2,268,522 | +9.6% | 0.08% | +10.7% |
| Q4 2017 | $341,556,000 | +222.6% | 2,069,103 | +21.8% | 0.08% | +212.5% |
| Q3 2017 | $105,860,000 | -16.1% | 1,699,209 | +7.2% | 0.02% | -20.0% |
| Q2 2017 | $126,185,000 | – | 1,584,449 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |